Smash Notes
What Kind of Teammate Thrives at Adaptive Technologies?
at 38:27
Answer
Common attributes such as debating openly and communicating ideas as well as the ability to be kind. Help people out, work collaboratively, and give credit where credit is due.
Where this answer comes from
- Show
- What Fuels You
- Episode
- #4 Chad Robins
- People
- Chad Robins
- Moment
- Date
People
On this episode
- Who Is Chad Robins of Adaptive Biotechnologies? Transcript
- What Does Adaptative Biotechnologies Do Transcript
- What Fuels Chad Robins Transcript
- What Was Chad's Childhood Like Transcript
- Would Chad Robins's Childhood Friends Have Pictured Him as a CEO? Transcript
- Who Influenced Chad When He Was Younger Transcript
- What Education of Great Value in His Home Transcript
- How Does Chad Robins Define a Successful Person? Transcript
- Why Did Chad Robins Choose Cornell for His Undergraduate Degree? Transcript
- How Did Chad's Experiences in Hedgefunds, Investment Banking, and the Real Estate Industry Prepare Him to Be a CEO Transcript
- What Skills End Up Differentiating Professionals Over Time Transcript
- What Is Chad's Passion Transcript
- Does Chad See a Common Thread in Successful Company Culture Transcript
- What Is Immunosequencing, According to Chad Robins? Transcript
- How Does Immunosequencing Work Transcript
- How Does Chad Robins Say Adaptive's Immunosequencing Platform Can Be Used? Transcript
- What Are Some Other Facets of Adaptive Technologies Transcript
- How Can Patients Access Adaptive Biotechnologies' clonoSEQ Test? Transcript
- How Does Chad Spend His Time Today vs. 2009 Transcript
- What Should You Spend Money on as the CEO Transcript
- What Kind of Teammate Thrives at Adaptive Technologies? Transcript
- What Are Some Time Management Hacks for a CEO Transcript
- How Does Chad Decompress Transcript
- What Fuels Chad in His Personal Life Transcript
More answers like this
- What Should You Spend Money on as the CEO
- What Are Some Time Management Hacks for a CEO
- How Does Chad Spend His Time Today vs. 2009
- How Can Patients Access Adaptive Biotechnologies' clonoSEQ Test?